Loading...

Tandem Autologous versus Single Autologous Transplantation Followed by Allogeneic Hematopoietic Cell Transplantation for Patients with Multiple Myeloma: Results from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0102 Trial

BACKGROUND: Autologous hematopoietic cell transplantation (HCT) improves survival in patients with multiple myeloma, but disease progression remains a challenge. Allogeneic HCT (alloHCT) has the potential to reduce disease progression through graft-versus-myeloma effects. The aim of the BMT CTN 0102...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Krishnan, Amrita, Pasquini, Marcelo C., Logan, Brent, Stadtmauer, Edward A., Vesole, David H., Alyea, Edwin, Antin, Joseph H., Comenzo, Raymond, Goodman, Stacey, Hari, Parameswaran, Laport, Ginna, Qazilbash, Muzaffar H., Rowley, Scott, Sahebi, Firoozeh, Somlo, George, Vogl, Dan T., Weisdorf, Daniel, Ewell, Marian, Wu, Juan, Geller, Nancy L., Horowitz, Mary M., Giralt, Sergio, Maloney, David G.
Format: Artigo
Sprog:Inglês
Udgivet: 2011
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3611089/
https://ncbi.nlm.nih.gov/pubmed/21962393
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1470-2045(11)70243-1
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!